Business Context and Reporting Period
This Form 8-K Current Report was filed by American BriVision (Holding) Corporation on February 11, 2021, regarding events occurring on February 8, 2021. The filing discloses the results of the Company's 2020 Annual Meeting of Shareholders. The Company is incorporated in Nevada and maintains its principal executive offices in Fremont, California.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance and shareholder voting outcomes rather than financial performance.
Material Changes and Voting Results
Shareholders voted on three proposals at the Annual Meeting, where 13,356,480 shares (63.85% of voting power) were represented, constituting a quorum. All three proposals were approved:
- Proposal 1: Re-election of Directors. Shareholders voted to re-elect all 11 directors to the Board of Directors. Each director received 12,787,039 votes "For," with zero votes "Against" and 2 votes "Withheld."
- Proposal 2: Ratification of Auditors. Shareholders ratified the appointment of KCCW Accountancy Corp. as the independent registered public accounting firm. The vote was 13,272,436 "For," 1 "Against," and 82,043 "Abstain."
- Proposal 3: Name Change. Shareholders approved an amendment to the Articles of Incorporation to change the corporate name to "ABVC BioPharma, Inc." The vote was 13,271,170 "For," 1 "Against," and 85,309 "Abstain."
Outlook, Risks, and Management Commentary
Management confirmed that the Company will file an amendment to its Articles of Incorporation to effectuate the name change to ABVC BioPharma, Inc. A subsequent Form 8-K will be filed once the amendment becomes effective. The filing notes that existing stock certificates remain valid and do not need to be exchanged; however, new certificates issued after the effective date will bear the new name. No specific financial risks, contingencies, or unusual items were disclosed in this report.
Investor Verification Checklist
- Verify the effective date of the name change to "ABVC BioPharma, Inc." via the subsequent Form 8-K filing.
- Confirm the continued validity of existing stock certificates under the new corporate name.
- Review the Company's next periodic report (10-K or 10-Q) for financial data, as this 8-K contains no financial metrics.
- Monitor the composition of the Board of Directors to ensure the re-elected members align with the Company's strategic direction.